open access

Vol 14, No 3 (2018)
Case report
Published online: 2018-06-21
Get Citation

A case of B-cell lymphoma of the uterus

Olivia Jakubowicz, Dominika Hempel, Marek Z. Wojtukiewicz, Ewa Sierko
DOI: 10.5603/OCP.2018.0022
·
Oncol Clin Pract 2018;14(3):164-166.

open access

Vol 14, No 3 (2018)
CASE REPORT
Published online: 2018-06-21

Abstract

Primary malignant lymphoma occurs rarely in the female reproductive tract. A case of a 64-year-old female patient diagnosed with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma (B-UCL) of the uterus is presented. The patient underwent three cycles of chemotherapy based on R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with rituximab), radiation therapy to the pelvis, and extended hysterectomy. The follow-up has been conducted for three years. No sign of disease recurrence has been observed in physical examination and on images.

Abstract

Primary malignant lymphoma occurs rarely in the female reproductive tract. A case of a 64-year-old female patient diagnosed with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma (B-UCL) of the uterus is presented. The patient underwent three cycles of chemotherapy based on R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with rituximab), radiation therapy to the pelvis, and extended hysterectomy. The follow-up has been conducted for three years. No sign of disease recurrence has been observed in physical examination and on images.
Get Citation

Keywords

uterus; B-cell lymphoma; Burkitt lymphoma; unclassifiable B-cell lymphoma; primary malignant lymphoma

About this article
Title

A case of B-cell lymphoma of the uterus

Journal

Oncology in Clinical Practice

Issue

Vol 14, No 3 (2018)

Article type

Case report

Pages

164-166

Published online

2018-06-21

DOI

10.5603/OCP.2018.0022

Bibliographic record

Oncol Clin Pract 2018;14(3):164-166.

Keywords

uterus
B-cell lymphoma
Burkitt lymphoma
unclassifiable B-cell lymphoma
primary malignant lymphoma

Authors

Olivia Jakubowicz
Dominika Hempel
Marek Z. Wojtukiewicz
Ewa Sierko

References (14)
  1. Vang R, Medeiros LJ, Ha CS, et al. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol. 2000; 13(1): 19–28.
  2. Okuda T, Ijichil S, Yamashita S, et al. Diagnostic usefulness of FDG-PET/CT in advanced malignant lymphoma of the uterus: report of two cases. Eur J Gynaecol Oncol. 2015; 36(6): 737–741.
  3. Mandato VD, Palermo R, Falbo A, et al. Primary diffuse large B-cell lymphoma of the uterus: case report and review. Anticancer Res. 2014; 34(8): 4377–4390.
  4. Samama M, van Poelgeest M. Primary malignant lymphoma of the uterus: a case report and review of the literature. Case Rep Oncol. 2011; 4(3): 560–563.
  5. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20): 2375–2390.
  6. Stroh EL, Besa PC, Cox JD, et al. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy. Cancer. 1995; 75(9): 2392–2399, doi: 10.1002/1097-0142(19950501)75:9<2392::aid-cncr2820750932>3.0.co;2-y.
  7. Cubo AM, Soto ZM, Cruz MÁ, et al. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report. Medicine (Baltimore). 2017; 96(19): e6846.
  8. Hashimoto A, Fujimi A, Kanisawa Y, et al. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report]. Gan To Kagaku Ryoho. 2013; 40(13): 2589–2592.
  9. Sharma V, Dora T, Patel M, et al. Case Report of Diffuse Large B Cell Lymphoma of Uterine Cervix Treated at a Semiurban Cancer Centre in North India. Case Rep Hematol. 2016; 2016: 3042531.
  10. Perry AM, Crockett D, Dave BJ, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. Br J Haematol. 2013; 162(1): 40–49.
  11. Zhao L, Ma Q, Wang Q, et al. Primary diffuse large B cell lymphoma arising from a leiomyoma of the uterine corpus. Diagn Pathol. 2016; 11: 9.
  12. Bürgesser MV, Gualco G, Diller A, et al. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina. Ann Diagn Pathol. 2013; 17(3): 250–255.
  13. Baryakh EA, Misyurina AE, Kovrigina AM, et al. [Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma]. Ter Arkh. 2015; 87(8): 77–85.
  14. Yahalom J, Illidge T, Specht L, et al. International Lymphoma Radiation Oncology Group. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015; 92(1): 11–31.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl